Contagious Periods for Common Winter Illnesses and Updated Isolation Guidelines
The CDC provides updated guidelines for ending isolation after contracting COVID-19, flu, and RSV: 24 hours fever-free without medication and improved symptoms; Norovirus contagiousness may last 2 weeks post-recovery; Pneumonia contagiousness typically decreases after 24 hours of antibiotics.
Contagious Periods for Common Winter Illnesses and Updated Isolation Guidelines
The CDC provides updated guidelines for ending isolation after contracting COVID-19, flu, and RSV: 24 hours fever-free without medication and improved symptoms; Norovirus contagiousness may last 2 weeks post-recovery; Pneumonia contagiousness typically decreases after 24 hours of antibiotics.
Progress
16% Bias Score
Dutch Entrepreneurs Face Trial for Alleged 100 Million Euro Mask Deal Fraud
Three Dutch entrepreneurs stand trial in Rotterdam, accused of defrauding Randstad, Coolblue, and the Dutch government in a 100 million euro mask deal during the COVID-19 pandemic; they deny the charges and claim they are victims of a smear campaign.
Dutch Entrepreneurs Face Trial for Alleged 100 Million Euro Mask Deal Fraud
Three Dutch entrepreneurs stand trial in Rotterdam, accused of defrauding Randstad, Coolblue, and the Dutch government in a 100 million euro mask deal during the COVID-19 pandemic; they deny the charges and claim they are victims of a smear campaign.
Progress
56% Bias Score
Retraction of High-Profile Hydroxychloroquine Covid-19 Study
Elsevier retracted a March 2020 study promoting hydroxychloroquine for Covid-19 due to ethical concerns raised by three of its authors and an investigation revealing issues with patient consent and equipoise, marking the highest-cited retracted Covid-19 paper.
Retraction of High-Profile Hydroxychloroquine Covid-19 Study
Elsevier retracted a March 2020 study promoting hydroxychloroquine for Covid-19 due to ethical concerns raised by three of its authors and an investigation revealing issues with patient consent and equipoise, marking the highest-cited retracted Covid-19 paper.
Progress
48% Bias Score
Retraction of 2020 Hydroxychloroquine COVID-19 Study Due to Ethical and Methodological Flaws
A 2020 study promoting hydroxychloroquine for COVID-19 treatment, published in the International Journal of Antimicrobial Agents and led by Philippe Gautret, has been retracted due to ethical concerns and methodological flaws, including a small sample size and issues with patient consent for azithro...
Retraction of 2020 Hydroxychloroquine COVID-19 Study Due to Ethical and Methodological Flaws
A 2020 study promoting hydroxychloroquine for COVID-19 treatment, published in the International Journal of Antimicrobial Agents and led by Philippe Gautret, has been retracted due to ethical concerns and methodological flaws, including a small sample size and issues with patient consent for azithro...
Progress
52% Bias Score
Spanish Court Clears Andalusian Health Service in Emergency Contract Probe
The Spanish Court of Auditors concluded its investigation into Andalusian Health Service emergency contracts, finding no accounting irregularities despite initial concerns, and the matter remains under judicial investigation.
Spanish Court Clears Andalusian Health Service in Emergency Contract Probe
The Spanish Court of Auditors concluded its investigation into Andalusian Health Service emergency contracts, finding no accounting irregularities despite initial concerns, and the matter remains under judicial investigation.
Progress
36% Bias Score
Pfizer's 2025 Forecast Meets Expectations Amidst Medicare Changes and Investor Scrutiny
Pfizer projects 2025 profits near analyst estimates, anticipating stable Covid-19 product sales despite a \$1 billion revenue reduction from Medicare changes and ongoing investor pressure following a 12% share decline this year.
Pfizer's 2025 Forecast Meets Expectations Amidst Medicare Changes and Investor Scrutiny
Pfizer projects 2025 profits near analyst estimates, anticipating stable Covid-19 product sales despite a \$1 billion revenue reduction from Medicare changes and ongoing investor pressure following a 12% share decline this year.
Progress
36% Bias Score
U.S. Flu Cases Surge, Doubling in a Week
The U.S. is experiencing a sharp increase in flu cases, with thirteen states reporting high or very high levels of flu-like illness last week, double the number from the week prior; experts warn of potential strain on healthcare systems and the importance of vaccination.
U.S. Flu Cases Surge, Doubling in a Week
The U.S. is experiencing a sharp increase in flu cases, with thirteen states reporting high or very high levels of flu-like illness last week, double the number from the week prior; experts warn of potential strain on healthcare systems and the importance of vaccination.
Progress
24% Bias Score
Families criticize slow pace of Scotland's Covid death probe
Relatives of over 6,000 people who died in Scotland during the Covid-19 pandemic are criticizing the slow pace of a Crown Office investigation, citing a lack of communication and information, while the investigation is hampered by complex issues and extensive delays.
Families criticize slow pace of Scotland's Covid death probe
Relatives of over 6,000 people who died in Scotland during the Covid-19 pandemic are criticizing the slow pace of a Crown Office investigation, citing a lack of communication and information, while the investigation is hampered by complex issues and extensive delays.
Progress
48% Bias Score
Dutch Entrepreneurs Face Fraud Trial Over COVID-19 Mask Deal
Three Dutch entrepreneurs stand trial in Rotterdam for allegedly defrauding the government and private companies during the COVID-19 pandemic by profiting millions from a mask deal, using a commercial business structure despite claiming non-profit status; the case involves 17,000 pages of evidence a...
Dutch Entrepreneurs Face Fraud Trial Over COVID-19 Mask Deal
Three Dutch entrepreneurs stand trial in Rotterdam for allegedly defrauding the government and private companies during the COVID-19 pandemic by profiting millions from a mask deal, using a commercial business structure despite claiming non-profit status; the case involves 17,000 pages of evidence a...
Progress
48% Bias Score
Retracted Hydroxychloroquine Study Highlights Risks of Premature Research and Misinformation
A 2020 study in the International Journal of Antimicrobial Agents promoting hydroxychloroquine as a COVID-19 treatment was retracted due to ethical and methodological concerns raised by the authors and the publisher, Elsevier, impacting researchers' careers and leading to the revocation of the FDA's...
Retracted Hydroxychloroquine Study Highlights Risks of Premature Research and Misinformation
A 2020 study in the International Journal of Antimicrobial Agents promoting hydroxychloroquine as a COVID-19 treatment was retracted due to ethical and methodological concerns raised by the authors and the publisher, Elsevier, impacting researchers' careers and leading to the revocation of the FDA's...
Progress
48% Bias Score
Retraction of Landmark Hydroxychloroquine Study for COVID-19
A study co-authored by Didier Raoult promoting hydroxychloroquine for COVID-19 treatment was retracted on December 17, 2023, by the International Journal of Antimicrobial Agents due to multiple ethical and methodological breaches, including concerns over results manipulation and lack of informed con...
Retraction of Landmark Hydroxychloroquine Study for COVID-19
A study co-authored by Didier Raoult promoting hydroxychloroquine for COVID-19 treatment was retracted on December 17, 2023, by the International Journal of Antimicrobial Agents due to multiple ethical and methodological breaches, including concerns over results manipulation and lack of informed con...
Progress
56% Bias Score
Western Australia Covid-19 Surge: 75 Daily Hospital Admissions
Western Australia is experiencing a surge in Covid-19 cases driven by Omicron subvariants, resulting in an average of 75 daily hospital admissions; authorities urge isolation for anyone with symptoms, mask-wearing in public, and vaccination with the new Pfizer JN.1 booster.
Western Australia Covid-19 Surge: 75 Daily Hospital Admissions
Western Australia is experiencing a surge in Covid-19 cases driven by Omicron subvariants, resulting in an average of 75 daily hospital admissions; authorities urge isolation for anyone with symptoms, mask-wearing in public, and vaccination with the new Pfizer JN.1 booster.
Progress
40% Bias Score